Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark - factors associated with risks and rates in adults according to conditioning regimen

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ultraviolet radiation drives mutations in a subset of mucosal melanomas

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 3D image-guided treatment planning for Ruthenium-106 brachytherapy of choroidal melanomas

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

We investigated risks and hazard rates of developing chronic ocular graft-versus-host disease (oGVHD) in a large nationwide, single centre study by using the criteria proposed by "The International Chronic oGVHD Consensus Group". This retrospective study included 1407 consecutive adults who underwent allogeneic haematopoietic stem cell transplantation (HSCT). Patients were examined by an ophthalmologist according to the hospital's guidelines: baseline examination before HSCT, annually up to 5 years after HSCT. The 186 (13%) had dry eye disease before HSCT. The 5-year cumulative incidence of oGVHD was 18% (95% CI: 15-21) after myeloablative (MA) and 35% (95% CI: 30-39) after non-myeloablative conditioning (NMA). Factors associated with the rate of oGVHD were assessed separately according to conditioning regimen by using multiple Cox regression analyses. Factors that increased the rate in the MA group: Malignant disease, Schirmer's test≤10 mm/5 min before transplantation, use of female donor, matched unrelated donor, peripheral blood as stem cell source, and grade III-IV acute GVHD. Factors that increased the rate in the NMA group: Schirmer's test≤10 mm/5 min before transplantation and higher recipient age. We recommend a baseline ophthalmological examination before HSCT since many of the patients have signs of dry eyes before transplantation which increased the risk and rate of developing oGVHD.

Original languageEnglish
JournalBone Marrow Transplantation
Volume56
Issue number1
Pages (from-to)144-154
Number of pages11
ISSN0268-3369
DOIs
Publication statusPublished - Jan 2021

    Research areas

  • Adult, Denmark, Female, Graft vs Host Disease/etiology, Hematopoietic Stem Cell Transplantation/adverse effects, Humans, Retrospective Studies, Transplantation Conditioning/adverse effects

ID: 61961075